Blog
Clinical trials and the novelty of the invention
Can clinical trials of a new medicine that are conducted before a patent application is filed result in the loss of novelty by that invention? The caselaw of the EPO shows that it is quite a serious risk that we should take into consideration when preparing the placing of our medicinal product on the European market. In this Report, we would like to take a closer look at one of the most...
The New EPO Guidelines: An Overview of the Key Changes
Since March 1, 2021 new Guidelines of the European Patent Office (EPO) are in force. Until now, such an update tended to take place annually in November; this shift in calendar is consistent with a broader plan of reforms related to the Strategic Plan 2023 being currently implemented by EPO, which among its key initiatives lists fostering social dialogue and engaging stakeholders. The new...